These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11190584)

  • 1. Electrophysiological mechanism of combination therapy with disopyramide and propranolol for paroxysmal atrial fibrillation.
    Gondo N; Kumagai K; Yamanouchi Y; Annoura M; Saku K
    J Cardiol; 2000 Dec; 36(6):405-10. PubMed ID: 11190584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of disopyramide in comparison with verapamil and propranolol in the prevention of acetylcholine-induced atrial fibrillation in the dog.
    Bertrix L; Timour Chah Q; Lang J; Lakhal M; Bouzouita K; Faucon G
    Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):97-110. PubMed ID: 4015264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electrophysiologic study of cibenzoline in patients with paroxysmal atrial fibrillation with special reference to atrial fibrillation threshold].
    Inoue D; Ishibashi K; Sakai R; Inoue M; Omori I; Asayama J; Nakagawa M
    Kokyu To Junkan; 1992 Dec; 40(12):1203-8. PubMed ID: 1480832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing.
    De Sisti A; Attuel P; Manot S; Fiorello P; Halimi F; Leclercq JF
    Europace; 2000 Oct; 2(4):304-11. PubMed ID: 11194597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the efficacies of disopyramide, cibenzoline and aprindine for the termination of paroxysmal and persistent atrial fibrillation in elderly and non-elderly patients].
    Komatsu T; Nakamura S; Suzuki O; Yomogida K; Horiuchi D; Abe N; Kameda K; Owada S; Tomita H; Oikawa K; Okumura K
    J Cardiol; 2003 Apr; 41(4):191-8. PubMed ID: 12728540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of pilsicainide hydrochloride on atrial fibrillation threshold].
    Ishibashi K; Inoue D; Omori I; Shirayama T; Inoue M; Sakai R; Yamahara Y; Asayama J; Nakagawa M
    Kokyu To Junkan; 1993 Aug; 41(8):763-7. PubMed ID: 8351435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prospective course of therapy arresting attacks of atrial fibrillation in patients with preexcitation syndromes].
    Fomina IG; Iankin VV
    Klin Med (Mosk); 1992 Feb; 70(2):37-40. PubMed ID: 1507816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of antiarrhythmic effects of class Ic drugs in paroxysmal atrial fibrillation in man.
    Matsuo K; Kumagai K; Annoura M; Ideishi M; Arakawa K
    Cardiology; 1998; 89(2):119-23. PubMed ID: 9524012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Factors for successful conversion of atrial fibrillation using intravenous injection of pilsicainide hydrochloride].
    Matsushita K; Ishikawa T; Sumita S; Kobayashi T; Matsumoto K; Yamakawa Y; Ohkusu Y; Nakagawa T; Nakazawa I; Mochida Y; Ebina T; Uchino K; Kimura K; Umemura S
    J Cardiol; 2003 Aug; 42(2):81-6. PubMed ID: 12964518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced dispersion of atrial refractoriness as an electrophysiological substrate for vulnerability to atrial fibrillation in patients with paroxysmal atrial fibrillation.
    Oliveira MM; da Silva N; Timóteo AT; Feliciano J; de Sousa L; Santos S; Marques F; Ferreira R
    Rev Port Cardiol; 2007; 26(7-8):691-702. PubMed ID: 17939579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of disopyramide on the atrial fibrillation threshold in the human atrium.
    Ishibashi K; Inoue D; Sakai R; Inoue M; Shirayama T; Asayama J; Nakagawa M
    Int J Cardiol; 1995 Nov; 52(2):177-84. PubMed ID: 8749880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent syncopic episodes as a consequence of combined Brugada syndrome and paroxysmal atrial fibrillation. Which is the therapy of choice?
    Eleftheriadis D; Panagiotis V; Eleftheriadis N
    Int J Cardiol; 2004 Apr; 94(2-3):319-20. PubMed ID: 15094000
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical assessment of antiarrhythmic agents for paroxysmal atrial fibrillation guided by modification of electrophysiologic arrhythmogenicity.
    Sasano T; Okishige K; Azegami K; Isobe M
    J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1250-7. PubMed ID: 15574173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
    J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased AAI mode pacing threshold after termination of atrial fibrillation by acute administration of disopyramide phosphate.
    Anzawa R; Ishikawa S; Tanaka Y; Okazaki F; Mochizuki S
    Europace; 2006 May; 8(5):345-8. PubMed ID: 16635993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biatrial pacing--new possibility in the non-pharmacologic treatment of drug-resistant paroxysmal atrial fibrillation].
    Merkely B; Vágó H; Gellér L; Zima E; Tomcsányi J; Bodor E
    Orv Hetil; 2001 Feb; 142(5):235-40. PubMed ID: 11243011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous MgSO4 alone and in combination with glucose, insulin and potassium (GIK) prolong the atrial cycle length in chronic atrial fibrillation.
    Ingemansson MP; Smideberg B; Olsson SB
    Europace; 2000 Apr; 2(2):106-14. PubMed ID: 11225936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs.
    Shiroshita-Takeshita A; Sakabe M; Haugan K; Hennan JK; Nattel S
    Circulation; 2007 Jan; 115(3):310-8. PubMed ID: 17224477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart rate variability is a useful parameter for evaluation of anticholinergic effect associated with inducibility of atrial fibrillation.
    Sugiura H; Chinushi M; Komura S; Hirono T; Aizawa Y
    Pacing Clin Electrophysiol; 2005 Nov; 28(11):1208-14. PubMed ID: 16359288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between duration of arrhythmia and subsequent preventive effect of disopyramide after cardioversion in patients with symptomatic paroxysmal and persistent atrial fibrillation].
    Komatsu T; Yomogida K; Nakamura S; Suzuki O; Horiuchi D; Kameda K; Tomita H; Abe N; Owada S; Oikawa K; Okumura K
    J Cardiol; 2003 Sep; 42(3):111-7. PubMed ID: 14526660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.